Parent education on HPV and the HPV vaccine
The Effect of Parent Education on Human Papillomavirus Vaccination Intention: A Randomized Controlled Trial
This program will try an educational session to see if teaching parents of 11–18-year-olds about HPV and the vaccine improves their knowledge and willingness to vaccinate.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 52 (estimated) |
| Ages | 11 Years to 49 Years |
| Sex | All |
| Sponsor | KTO Karatay University Academic / other |
| Locations | 1 site (Konya) |
| Trial ID | NCT07447245 on ClinicalTrials.gov |
What this trial studies
This interventional project enrolls Turkish-speaking parents aged 18–49 who have a child aged 11–18 and whose child has not yet received the HPV vaccine. Participants will receive structured education about HPV transmission, cancer risks, and the benefits and safety of vaccination, with outcomes measured before and after the session. The intervention is delivered at KTO Karatay University in Konya, Turkey, and excludes parents with hearing or speech impairments or those whose children are already vaccinated. The study aims to change parental knowledge and vaccination intent, and may track subsequent vaccine uptake.
Who should consider this trial
Good fit: Ideal candidates are Turkish-literate parents aged 18–49 with an unvaccinated child aged 11–18 who can attend the session and consent to participate.
Not a fit: Parents whose children have already received the HPV vaccine, who cannot read Turkish, or who cannot attend in Konya are unlikely to benefit from this program.
Why it matters
Potential benefit: If successful, the education could raise parental knowledge and acceptance of HPV vaccination and increase vaccine uptake among adolescents.
How similar studies have performed: Previous education interventions have often increased parental knowledge and improved HPV vaccine acceptance and uptake in comparable settings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Parent must be between 18-49 years old * Parent must be a child aged 11-18 * Parent must not have hearing or speech problems * Parent must be able to read and write in Turkish * Parent must agree to participate in the study Exclusion Criteria: • Parents of children who have received the HPV vaccine
Where this trial is running
Konya
- Kto Karatay University — Konya, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Funda Gürbüz, Öğr. Gör
- Email: funda.gurbuz@karatay.edu.tr
- Phone: 05065005321
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.